Poor timing and indication choices can leave scars after medical intervention, sometimes more problematic than treatment of the hemangioma itself. Parents should be aware that the goals of hemangioma treatment are: 1. to prevent life- and function-threatening complications of hemangioma, to prevent and reduce disfigurement and deformity, and to appropriately address bleeding, infection, pain and suffering caused by necrotic ulcers and to reduce the psychosocial burden on the patient and family. 2.For the choice of treatment for pediatric hemangioma, it should be based on the size and location of the lesion, the complications that arise, the possibility of scar formation and disfigurement, the age of the child, the growth status, the growth range of the tumor, the evaluation of the pros and cons of treatment, including the conditions of medical treatment, and the experience of the doctor. 3. The pediatric surgery, pediatric dermatology, vascular malformation team or other relevant specialists should consult together to ensure that the actual and potential risk of complications for the child with hemangioma corresponds to the relevant treatment plan. 4. Parents and all family members of children with hemangioma should be informed of the possible course of the hemangioma; possible complications; indications for treatment; pros and cons of treatment; and prognosis of various treatments. During the progressive phase of hemangioma, it is important to continually evaluate, especially before enrollment, the lesions in a series of photographs to compare changes at follow-up. 5. I advocate against aggressive management of uncomplicated hemangiomas, which requires regular observation of the clinical course and attention to the psychosocial impact on the child and family. 6. Lesions requiring treatment are generally of a type that affects major structures and functions, or delaying treatment may increase the risk of rupture, scarring, and disfigurement. For example, hemangioma growing in the respiratory tract, liver, gastrointestinal tract, around the orbit or other facial five senses, facial stage distribution, hemangioma very large fast growing skin hemangioma. 7.Hemangioma around the orbit should be consulted by an ophthalmologist who has experience in treating hemangioma. 8.The basic treatment for ulcerated lesions is careful trauma care and pain relief. 9.Systemic glucocorticoids (such as prednisone) are recommended as the first-line drug treatment for hemangioma with high output heart failure, but hormones have certain side effects, mainly suppression of immunity triggering infection, possible inhibition of pediatric growth, obesity and osteonecrosis, mainly occurring in long-term mass users, children with hemangioma are applied in general doses, and the size of side effects is related to treatment indications, response, and age at the time of application. 10.I recommend oral propranolol (proprandol) for the treatment of hemangioma with potentially damaging function or causing disfigurement (such as orbital hemangioma) as the first-line drug; the side effects of proprandol are less and lighter, and oral prednisone can be used if you have asthma; for severe or refractory cases (such as respiratory hemangioma), proprandol and prednisone are recommended to be used together. 11.Vincristine and α-interferon can be used as an option for progressive hemangioma, and they are suitable for those who do not respond to the insulin or hormone. I recommend vincristine over alpha-interferon because the latter has a greater side effect of neurological damage. There is a clinical observation study of drug treatment of hemangioma: 68 cases of pediatric hemangioma, the area of hemangioma fading >75% and side effects were 82% and 2.9% in the take-home pay group and 29% and 100% in the hormone; after 3-8 months of treatment with poor results and the need for surgery, 12% in the take-home pay group and 29% in the hormone group. Non-pharmacological treatment, including laser, surgical resection, thermal necrolysis therapy such as radiofrequency, radiation therapy, freezing, vascular embolization method (DSA).